SCHEMBL104379

SCHEMBL104379

CC1(C)OCOC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17931783 0.84
SCHEMBL17931772 0.84
SCHEMBL17931748 0.81
SCHEMBL85966 0.76
SCHEMBL4404074 0.73
SCHEMBL17931777 0.71
SCHEMBL17931753 0.71
SCHEMBL17931757 0.67
SCHEMBL10597003 0.67
SCHEMBL13959269 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109216647-B Bipolar electrode plate, bipolar battery containing electrode plate and maintenance and regeneration method 北京好风光储能技术有限公司 2022-02-22 CN claimed
WO-2020026162-A1 PROCESS FOR THE MULTISTEP CONTINUOUS-FLOW PREPARATION OF FLIBANSERIN RICHTER GEDEON NYRT. (HU) 2020-02-06 WO claimed
US-12351780-B2 Peptide acetals for stabilising enzymes BASF SE (DE) 2025-07-08 US disclosed
EP-3865501-B1 NEW INTERMEDIATES FOR THE PREPARATION OF 11-METHYLENE STEROIDS CURIA SPAIN S A U (ES) 2025-04-30 EP disclosed
US-12227537-B2 Intermediates for the preparation of 11-methylene steroids CRYSTAL PHARMA, S.A.U. (ES) 2025-02-18 US disclosed
US-12220419-B2 BCL-2 inhibitors NEWAVE PHARMACEUTICAL INC. (US) 2025-02-11 US disclosed
US-11903950-B2 BCL-2 inhibitors NEWAVE PHARMACEUTICAL INC. (US) 2024-02-20 US disclosed
WO-2024032647-A1 PREPARATION METHOD FOR NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITOR, AND APPLICATION AND USE THEREOF 上海济煜医药科技有限公司 2024-02-15 WO disclosed
US-20230295183-A1 HOT MELT EXTRUDED SOLID DISPERSIONS CONTAINING A BCL2 INHIBITOR NEWAVE PHARMACEUTICAL INC. 2023-09-21 US disclosed
US-11708381-B2 Inhibitors of androgen receptor signaling XAVIER UNIVERSITY OF LOUISIANA (US) 2023-07-25 US disclosed
CN-113889676-B Repairing and regenerating method for lithium-containing battery 北京好风光储能技术有限公司 2023-06-20 CN disclosed
US-7825205-B2 Process for the preparation of SiOC-linked, linear polydimethylsiloxane-polyoxyalkylene block copolymers and their use EVONIK GOLDSCHMIDT GMBH (DE) 2010-11-02 US disclosed
US-7825206-B2 Process for reacting polyorganosiloxanes and their use EVONIK GOLDSCHMIDT GMBH (DE) 2010-11-02 US disclosed
US-7799926-B2 Polar dyes CEPHEID (US) 2010-09-21 US disclosed
US-20100184979-A1 NEW PROCESS FOR PREPARING 2-(3--PHENYL)-2-METHYLPROPRIONIC ACID SANOFI-AVENTIS (FR) 2010-07-22 US disclosed
US-20090162319-A1 REVERSE TRANSCRIPTASE INHIBITORS ARDEA BIOSCIENCES (US) 2009-06-25 US disclosed
US-7442666-B2 Catalytic system for the dehydrogenative condensation of polyorganosiloxanes with alcohols and a process for preparing organically modified polyorganosiloxanes GOLDSCHMIDT GMBH (DE) 2008-10-28 US disclosed
US-20080153992-A1 Process for the preparation of SiOC-linked, linear polydimethylsiloxane-polyoxyalkylene block copolymers and their use EVONIK GOLDSCHMIDT GMBH (DE) 2008-06-26 US disclosed
US-20080153934-A1 Process for reacting polyorganosiloxanes and their use EVONIK GOLDSCHMIDT GMBH (DE) 2008-06-26 US disclosed
US-20070299231-A1 POLYSILOXANES CONTAINING (METH)ACRYLIC ESTER GROUPS ATTACHED VIA SiOC GROUPS, PROCESSES FOR PREPARING THEM AND THEIR USE AS A RADIATION-CURABLE ADHESIVE COATING GOLDSCHMIDT GMBH (DE) 2007-12-27 US disclosed